ZEPHYRx and NIOX today announced they have partnered to integrate FeNO by NIOX® into the ZEPHYRx Respiratory Cloud Platform to advance clinical research by offering one source of truth for multiple respiratory endpoints. ZEPHYRx, a health information technology innovator, has quickly become an industry leader in respiratory monitoring solutions for hybrid clinical research. In working with sponsors, ZEPHYRx and NIOX recognized a need for a more seamless solution by integrating FeNO by NIOX® measurements into the ZEPHYRx platform. NIOX, the world leader in FeNO testing, is the partner of choice for ZEPHYRx to further expand its offering for clinical research.

EverythingALS, has initiated a new study, The Radcliff Study, with partners in the quest to find a diagnosis, treatment, and cure for ALS. EverythingALS is teaming up with Aural Analytics, FeetMe, ZEPHYRx, and a major pharmaceutical company. The Radcliff Study is a novel research-as-a-feasibility study to inform the likelihood of success for a pre-competitive collaboration focused on developing an end-to-end digital alternative for the ALSFRS-R that supports clinically meaningful outcomes tailored for use in ALS.

RxCap, Inc., cloud-based remote monitoring enablement company, and ZEPHYRx LLC, a remote respiratory monitoring solutions provider, announced that they have entered into a partnership to integrate the ZEPHYRx cloud spirometry platform with RxCap's remote monitoring platform. With this new partnership, RxCap's enterprise customers, such as providers and payers, will be able to monitor the lung function of their patients and members with serious pulmonary conditions. By partnering with RxCap, enterprises can quickly build revenue-generating RPM programs that integrate with their existing care workflows and provide seamless experiences for their patients and members.

ZEPHYRx, LLC and MIR, Medical International Research, today announced they have entered into an exclusive partnership to jointly market the ZEPHYRx Remote Respiratory Monitoring (RRM) Solution. Under the new partnership, this will be the only remote patient monitoring (RPM) solution offered by MIR in North America. ZEPHYRx, a health information technology innovator, has quickly become an industry leader in RPM solutions for respiratory health. ZEPHYRx is the largest reseller of MIR’s Spirobank® Smart Spirometer and has been working with MIR, a global leader in medical devices and software, since its inception in 2019. With MIR’s well-established customer base and highly qualified sales personnel, MIR is the partner of choice for ZEPHYRx to fuel its path of accelerating growth.